Chapter 2 Antiangiogenic drugs: Chemosensitizers for combination cancer therapy
Donnini S, Filippelli A, Ciccone V, Spini A, Ristori E, Ziche M, Morbidelli L. Chapter 2 Antiangiogenic drugs: Chemosensitizers for combination cancer therapy. 2022, 29-66. DOI: 10.1016/b978-0-323-90190-1.00008-1.Peer-Reviewed Original ResearchImmune-competent T cellsAntiangiogenic drugsVascular normalizationT cellsTumor vasculatureTumor microenvironmentTumor areaImmune checkpoint inhibitorsAnticancer drugsCheckpoint inhibitorsImmune therapyAdvanced tumorsCombination therapyPromising chemosensitizerAntiangiogenic therapyTarget therapyTumor disseminationAnticancer chemoClinical developmentEffective deliverySolid tumorsTherapyTumor progressionTumor resistanceTumor angiogenesis